Kidney Tumour on Ultrasound or CT: Does It Always Mean Cancer?

Finding a kidney tumour or renal mass on an ultrasound or CT scan can be alarming—particularly when the scan was performed for an entirely unrelated reason.

One of the first questions patients ask is:

“Does a mass in my kidney mean I have kidney cancer?”

The answer is no.

Not every kidney mass is cancer. Some are simple cysts, some are benign tumours, and some small renal masses may never become clinically significant. However, certain imaging features can strongly suggest renal cell carcinoma (RCC) and require further evaluation.

The important question is therefore not simply:

“Is there a mass?”

but rather:

“What type of renal mass is it, what is the probability that it is malignant, and does it require treatment?”

What Is a Renal Mass?

A renal mass is an abnormal area identified within the kidney on imaging.

Broadly, kidney masses can be divided into:

Cystic masses – containing predominantly fluid.

Solid masses – composed predominantly of tissue.

Some lesions have both solid and cystic components.

This distinction is important because the probability of malignancy and subsequent management can differ substantially between these groups.

---

How Are Kidney Tumours Commonly Detected?

Many kidney tumours today are discovered incidentally.

For example, a patient may undergo ultrasound or CT for:

• Abdominal discomfort
• Gallstones
• Liver disease
• Kidney stones
• Urinary symptoms
• Routine health evaluation
• An unrelated abdominal condition

The scan unexpectedly identifies a renal mass.

This is sometimes referred to as an incidental renal mass.

Because imaging has become increasingly common, kidney tumours are frequently diagnosed before they produce any symptoms.

---

Does a Kidney Mass Always Cause Symptoms?

No.

Many small kidney cancers cause no symptoms at all.

When symptoms do occur, they can include:

• Blood in the urine
• Persistent pain in the flank
• An abdominal or flank mass
• Unexplained weight loss
• Loss of appetite
• Anaemia
• Fatigue

However, the absence of these symptoms does not rule out kidney cancer.

This is why an incidentally detected renal mass should be evaluated according to its imaging characteristics rather than whether the patient feels well.

---

Does Every Kidney Mass Mean Kidney Cancer?

No.

Several benign conditions can appear as renal masses.

Examples include:

Simple renal cysts

Simple cysts are extremely common, particularly with increasing age.

A typical simple renal cyst has characteristic imaging features and generally does not require cancer treatment.

Angiomyolipoma

An angiomyolipoma (AML) is a benign kidney tumour containing varying amounts of blood vessels, muscle and fat.

The presence of visible macroscopic fat on CT can often suggest the diagnosis.

However, some AMLs contain little visible fat and can be more difficult to distinguish from kidney cancer on imaging.

Oncocytoma

A renal oncocytoma is another benign kidney tumour.

The difficulty is that oncocytoma can sometimes look very similar to renal cell carcinoma on CT or MRI.

Imaging alone therefore cannot reliably determine the exact pathology of every solid renal mass.

---

What Is Renal Cell Carcinoma?

Renal cell carcinoma (RCC) is the most common type of kidney cancer in adults.

Several different subtypes exist, including:

• Clear-cell renal cell carcinoma
• Papillary renal cell carcinoma
• Chromophobe renal cell carcinoma
• Other less common subtypes

The exact subtype is usually established by examining tumour tissue obtained through biopsy or surgery.

Importantly, cancers arising from the renal pelvis are biologically different from conventional renal cell carcinoma and are generally treated as urothelial cancers rather than RCC.

---

What Does “Enhancing Renal Mass” Mean?

This is an important phrase that patients may encounter in their CT or MRI report.

When contrast is administered during a CT or MRI, radiologists assess whether the mass takes up contrast.

This is called enhancement.

A solid renal mass demonstrating significant enhancement raises suspicion for renal cell carcinoma.

However:

Enhancement does not automatically prove cancer.

Some benign renal tumours can also enhance.

The scan therefore helps estimate the probability of malignancy and define the anatomy, but the final pathological diagnosis may only become available after biopsy or surgery.

---

Is Ultrasound Enough to Diagnose Kidney Cancer?

Ultrasound is often excellent at detecting a kidney abnormality and distinguishing a straightforward simple cyst from a solid lesion.

However, if ultrasound demonstrates a solid or complex renal mass, further characterisation is usually required.

This commonly involves a contrast-enhanced CT scan or MRI.

These investigations provide considerably more information regarding:

• Tumour size
• Exact location
• Relationship to the kidney
• Enhancement characteristics
• Relationship to renal blood vessels
• Involvement of the collecting system
• Extension outside the kidney
• Renal vein or vena cava involvement
• Regional lymph nodes
• Possible metastatic disease

For surgical planning, these anatomical details can be extremely important.

---

CT or MRI: Which Is Better for a Kidney Tumour?

For many patients, a properly performed contrast-enhanced CT scan provides the information required to characterise and stage a renal mass.

MRI can be particularly useful in selected circumstances, such as:

• Inconclusive CT findings
• Certain complex cystic lesions
• Assessment of venous involvement
• Situations where iodinated CT contrast cannot be used
• Specific questions regarding tumour anatomy

The choice depends upon the patient's kidney function, previous imaging and the clinical question that needs to be answered.

---

What Is a Complex Kidney Cyst?

Not every cyst is a harmless simple cyst.

Some renal cysts contain:

• Thickened walls
• Septations
• Calcification
• Nodules
• Solid enhancing components

These are referred to as complex cystic renal masses.

Radiologists commonly classify these lesions using the Bosniak classification, which helps estimate the probability of malignancy and guide management.

A simple cyst and a complex cystic renal mass should therefore not be treated as equivalent findings.

---

Does the Size of a Kidney Tumour Matter?

Yes—but size is only one part of the assessment.

For tumours confined to the kidney, size contributes directly to clinical staging.

Broadly:

T1a: tumour up to 4 cm and confined to the kidney

T1b: tumour greater than 4 cm but not greater than 7 cm and confined to the kidney

T2: tumour greater than 7 cm but still confined to the kidney

More advanced T categories reflect extension into important veins or tissues outside the kidney rather than simply increasing size.

However, treatment decisions should not be based on size alone.

A 3 cm tumour in a difficult central location may present a very different surgical problem from a 5 cm tumour projecting outward from the kidney.

---

Why Does the Location of the Kidney Tumour Matter?

When planning kidney cancer surgery, surgeons assess considerably more than the tumour's maximum diameter.

Important anatomical features include:

• Whether the tumour is peripheral or central
• Whether it projects outside the kidney or grows deeply within it
• Proximity to the renal artery and vein
• Relationship to the urinary collecting system
• Anterior or posterior location
• Upper-, middle- or lower-pole location
• Depth of tumour within the kidney

These factors determine the complexity of partial nephrectomy and whether the kidney can be safely preserved.

This is why two renal tumours of exactly the same size may require very different operations.

---

Does Every Small Kidney Tumour Need Immediate Surgery?

No.

This is another important misconception.

A small renal mass does not automatically mean:

“Cancer suspected → kidney must immediately be removed.”

Depending upon the patient's age, health, tumour characteristics and competing medical risks, management options may include:

• Active surveillance
• Renal mass biopsy
• Partial nephrectomy
• Ablative treatment in selected patients
• Radical nephrectomy when appropriate

The objective is to balance cancer control with preservation of kidney function and avoidance of unnecessary treatment.

---

What Is Active Surveillance?

Active surveillance means monitoring a renal mass with planned imaging rather than immediately treating it.

This may be appropriate for selected patients, particularly when the renal mass is small and the risks of intervention may outweigh the immediate oncological benefit.

Surveillance does not mean ignoring the tumour.

It involves structured follow-up to assess:

• Tumour size
• Growth rate
• Changes in imaging characteristics
• Patient health
• Whether indications for intervention develop

If the tumour demonstrates concerning behaviour, treatment can subsequently be considered.

---

Do I Need a Biopsy of the Kidney Tumour?

Not every renal mass requires biopsy before treatment.

This often surprises patients because biopsy is routinely performed before treating many other cancers.

A renal mass biopsy can be useful when the result is likely to change management.

For example, it may help in selected patients considering:

• Active surveillance
• Ablative treatment
• Systemic therapy
• Situations where the diagnosis is uncertain
• Cases where identifying a benign tumour could potentially avoid unnecessary surgery

However, if imaging demonstrates a highly suspicious renal mass in a fit patient for whom surgery is already clearly indicated, biopsy may not always be necessary.

The key principle is:

Perform a biopsy when knowing the histology is likely to influence what you do next.

---

If It Is Kidney Cancer, Does the Entire Kidney Need to Be Removed?

Not necessarily.

This is one of the most important developments in modern kidney cancer surgery.

When technically and oncologically appropriate, a tumour can be removed while preserving the remaining healthy kidney.

This operation is called a:

Partial nephrectomy

The tumour is removed with an appropriate margin while the remainder of the kidney is preserved.

In contrast:

Radical nephrectomy

involves removal of the entire kidney, usually with surrounding tissue as appropriate.

For many localised renal tumours—particularly smaller tumours—partial nephrectomy is an important treatment option because it combines cancer control with preservation of functioning kidney tissue.

---

Why Is Preserving Kidney Function Important?

The kidneys perform several essential functions, including:

• Filtering waste products from the blood
• Maintaining fluid balance
• Regulating electrolytes
• Contributing to blood-pressure regulation
• Supporting red-blood-cell production

Preserving functioning renal tissue is particularly important in patients with:

• Chronic kidney disease
• Diabetes
• Hypertension
• A solitary kidney
• Bilateral kidney tumours
• Younger age and long life expectancy

Therefore, when cancer control can be achieved safely with partial nephrectomy, preservation of healthy kidney tissue can have important long-term benefits.

---

Can Partial Nephrectomy Be Performed Robotically?

Yes.

In appropriately selected patients, robot-assisted partial nephrectomy allows the surgeon to remove the kidney tumour while preserving the remainder of the kidney through a minimally invasive approach.

The robotic platform provides magnified three-dimensional vision and articulated instruments, which can be useful during precise tumour excision and reconstruction of the kidney.

However, not every kidney tumour should automatically undergo robotic partial nephrectomy.

The appropriate approach depends upon:

Tumour anatomy + kidney function + patient factors + oncological considerations + surgeon experience

The objective is not simply to perform robotic surgery.

The objective is complete cancer removal while preserving as much healthy functioning kidney as safely possible.

---

Can Large or Complex Kidney Tumours Still Be Treated With Partial Nephrectomy?

Sometimes.

Tumour size alone does not determine whether partial nephrectomy is possible.

Some larger tumours that project away from important renal structures may still be suitable for kidney-preserving surgery.

Conversely, a smaller tumour located deep within the kidney and close to major blood vessels or the collecting system may be technically much more complex.

This is why assessment by a surgeon experienced in kidney cancer and nephron-sparing surgery can be particularly valuable before deciding that the entire kidney must be removed.

---

What If I Have Only One Functioning Kidney?

A tumour in a solitary functioning kidney requires particularly careful planning.

Removing the entire functioning kidney could result in severe renal failure and potentially dialysis.

When oncologically and technically feasible, partial nephrectomy becomes especially important in this situation.

These operations can sometimes be complex, but the potential benefit of preserving functioning renal tissue is substantial.

The treatment plan needs to balance two equally important objectives:

Adequate cancer control + maximum safe preservation of kidney function

---

What If the Scan Suggests the Cancer Has Spread?

If imaging suggests disease outside the kidney, the treatment pathway changes.

Further staging may assess involvement of:

• Regional lymph nodes
• Lungs
• Bones in appropriate circumstances
• Liver
• Other organs

Modern treatment for metastatic renal cell carcinoma increasingly involves immunotherapy and targeted therapies.

Surgery may still have a role in selected patients, but the decision regarding nephrectomy needs to be made in the context of the overall disease burden, tumour biology, symptoms and systemic treatment strategy.

---

What Should You Ask After a Kidney Tumour Is Found?

If a renal mass has been identified on ultrasound, CT or MRI, useful questions include:

1. Is the lesion solid or cystic?

2. Does it enhance with contrast?

3. How large is it?

4. Where exactly is it located within the kidney?

5. Is it confined to the kidney?

6. Are the renal vein or surrounding structures involved?

7. Is there any evidence of spread elsewhere?

8. Do I need a renal mass biopsy?

9. Is active surveillance reasonable?

10. If surgery is required, can my kidney be preserved with partial nephrectomy?

These questions provide a much clearer framework than simply asking:

“Is this cancer?”

---

Kidney Tumour and Kidney Cancer Treatment in Lucknow

An incidentally detected renal mass should not automatically lead to removal of the entire kidney.

The first step is careful characterisation of the tumour and assessment of the patient.

At Uro-Onco Connect, Lucknow, evaluation of patients with renal masses focuses on:

Imaging review → assessment of malignancy risk → tumour size and anatomical complexity → kidney function → clinical staging → role of renal mass biopsy → active surveillance where appropriate → partial versus radical nephrectomy → selection of surgical approach

When surgery is required, particular attention is given to whether the tumour can be removed using nephron-sparing surgery, including robot-assisted partial nephrectomy in appropriately selected patients.

The fundamental principle is straightforward:

Finding a kidney tumour does not automatically mean losing the kidney.

The objective is to achieve appropriate cancer control while preserving as much healthy kidney function as safely possible.

About Dr. Anshuman Singh

Dr. Anshuman Singh
M.S., M.Ch. Urology (Gold Medalist)
Fellowship – Uro-Oncology & Robotic Surgery (USI, Intuitive Certified)
Visiting Fellow – Robotic Uro-Oncology (Fundació Puigvert, Spain)
Clinical Observer – Robotic Pelvic Oncology (University College London Hospitals, London)

Vice Chairperson – Uro-Oncology & Robotic Surgery
Chandan Cancer Institute, Chandan Hospital
Lucknow

Dr. Anshuman Singh is a Uro-Oncology and Robotic Surgery specialist in Lucknow with dedicated training in the surgical management of urological cancers. His clinical practice focuses on kidney cancer, prostate cancer, bladder cancer, testicular cancer, penile cancer and other complex urological malignancies, with particular emphasis on uro-oncological and robot-assisted surgery.

Patients diagnosed with a kidney tumour, renal mass or suspected kidney cancer can seek specialist uro-oncology consultation regarding imaging assessment, renal mass biopsy, active surveillance, partial nephrectomy, radical nephrectomy and robot-assisted kidney-preserving surgery.

References

1. European Association of Urology. EAU Guidelines on Renal Cell Carcinoma. EAU Guidelines Office, Arnhem, The Netherlands.
2. American Urological Association. Renal Mass and Localized Renal Cancer: Evaluation, Management, and Follow-Up: AUA Guideline.
3. National Cancer Institute. Renal Cell Cancer Treatment (PDQ®) – Health Professional Version.
4. National Cancer Institute. Renal Cell Cancer Treatment (PDQ®) – Patient Version.
5. European Association of Urology Patient Information. Partial Nephrectomy for Localised Kidney Cancer. Updated 2026.